Skip to main content
Livermore
Livermore
ZHEN

Renaissance Group LLC

SEC CIK
0000944234
Latest filing
Aug 13, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Renaissance Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,008
Value
$500.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Renaissance Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,008$500.6K<0.1%−64−6.0%ReducedHolders
Q1 20261,072$478.9K<0.1%−361−25.2%ReducedHolders
Q4 20251,433$649.6K<0.1%−35−2.4%ReducedHolders
Q3 20251,468$574.7K<0.1%−51−3.4%ReducedHolders
Q2 20251,519$676.3K<0.1%−195−11.4%ReducedHolders
Q1 20251,714$830.9K<0.1%−1,468−46.1%ReducedHolders
Q4 20243,182$1.28M0.1%−42−1.3%ReducedHolders
Q3 20243,224$1.50M0.1%−70,255−95.6%ReducedHolders
Q2 202473,479$34.4M1.3%−4,217−5.4%ReducedHolders
Q1 202477,696$32.5M1.2%−11,236−12.6%ReducedHolders
Q4 202388,932$36.2M1.5%−3,339−3.6%ReducedHolders
Q3 202392,271$32.1M1.5%−1,660−1.8%ReducedHolders
Q2 202393,931$33.1M1.4%−1,723−1.8%ReducedHolders
Q1 202395,654$30.1M1.4%+50+0.1%AddedHolders
Q4 202295,604$27.6M1.4%−748−0.8%ReducedHolders
Q3 202296,352$27.9M1.5%−9,916−9.3%ReducedHolders
Q2 2022106,268$29.9M1.5%−29,038−21.5%ReducedHolders
Q1 2022135,306$35.3M1.6%+10,191+8.1%AddedHolders
Q4 2021125,115$27.5M1.1%+6,265+5.3%AddedHolders
Q3 2021118,850$21.6M0.9%+17,365+17.1%AddedHolders
Q2 2021101,485$20.5M0.9%−5,095−4.8%ReducedHolders
Q1 2021106,580$22.9M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.